PROCEPT INC
4, 1997-09-10
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: PROCEPT INC, 4, 1997-09-10
Next: KRYSTAL COMPANY, PRER14A, 1997-09-10



UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
( ) Check this box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue. See Instructions 1(b).
1. Name and Address of Reporting Person
   Aries, Domestic Fund, LP
   787 Seventh Avenue
   48th Floor
   New York, NY  10019
2. Issuer Name and Ticker or Trading Symbol
   Procept Incorporated
   PRCT
3. IRS or Social Security Number of Reporting Person (Voluntary)
   
4. Statement for Month/Year
   08/97
5. If Amendment, Date of Original (Month/Year)
   
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
   ( ) Director (X) 10% Owner ( ) Officer (give title below) ( ) Other
   (specify below)
   
7. Individual or Joint/Group Filing (Check Applicable Line)
   (X) Form filed by One Reporting Person
   ( ) Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned                                                 |
___________________________________________________________________________________________________________________________________|
1. Title of Security       |2.    |3.    |4.Securities Acquired (A)         |5.Amount of        |6.Dir |7.Nature of Indirect       |
                           | Transaction |  or Disposed of (D)              |  Securities       |ect   |  Beneficial Ownership     |
                           |      |      |                                  |  Beneficially     |(D)or |                           |
                           |      |    | |                  | A/|           |  Owned at         |Indir |                           |
                           | Date |Code|V|    Amount        | D |    Price  |  End of Month     |ect(I)|                           |
___________________________________________________________________________________________________________________________________|
<S>                        <C>    <C>  <C><C>               <C> <C>         <C>                 <C>    <C>
Common Stock, $.01 par valu|08/22/|J(1)| |2,090,667 (3)     | D |$.46875 (2)|     0             |   D  |                           |
e per share                |97    |    | |                  |   |(3)        |                   |      |                           |
                           |      |    | |                  |   |           |                   |      |                           |
                           |      |    | |                  |   |           |                   |      |                           |

___________________________________________________________________________________________________________________________________|
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned                                                   |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative |2.Con-  |3.   |4.    |5.Number of De |6.Date Exer|7.Title and Amount  |8.Price|9.Number    |10.|11.Nature of|
  Security            |version |Transaction | rivative Secu |cisable and|  of Underlying     |of Deri|of Deriva   |Dir|Indirect    |
                      |or Exer |     |      | rities Acqui  |Expiration |  Securities        |vative |tive        |ect|Beneficial  |
                      |cise    |     |      | red(A) or Dis |Date(Month/|                    |Secu   |Securities  |(D)|Ownership   |
                      |Price of|     |      | posed of(D)   |Day/Year)  |                    |rity   |Benefi      |or |            |
                      |Deriva- |     |      |               |Date |Expir|                    |       |ficially    |Ind|            |
                      |tive    |     |      |           | A/|Exer-|ation|   Title and Number |       |Owned at    |ire|            |
                      |Secu-   |     |    | |           | D |cisa-|Date |   of Shares        |       |End of      |ct |            |
                      |rity    |Date |Code|V|  Amount   |   |ble  |     |                    |       |Month       |(I)|            |
___________________________________________________________________________________________________________________________________|
<S>                   <C>      <C>   <C>  <C><C>        <C> <C>   <C>   <C>          <C>     <C>     <C>          <C> <C>
- -----------------------------------------------------------------------------------------------------------------------------------|
Series A Convertible P|$.46875(|08/22|J(1)| |9,800      |A  |08/22|N/A  |Common Stock|2,090,6|$100.00|9,800       |D  |            |
referred Stock, par va|3)      |/97  |    | |           |   |/97  |     |            |67(3)  |       |            |   |            |
lue $.01 per share    |        |     |    | |           |   |     |     |            |       |       |            |   |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
                      |        |     |    | |           |   |     |     |            |       |       |            |   |            |
___________________________________________________________________________________________________________________________________|
</TABLE>
Explanation of Responses:
(1)  Pursuant to a  securities  purchase  agreement,  dated as of June 30, 1997,
between the  Reporting  Person,  the Aries  Trust and the Issuer (the  "Purchase
Agreement"),  since  the  approval  by  the  stockholders  of the  Issuer  of an
amendment to the Issuer's Certificate of Incorporation authorizing "blank check"
preferred  stock,  the Reporting Person elected to put (the "Put") its 2,090,667
shares of Common Stock purchased under the Purchase  Agreement to the Issuer for
Series A Convertible Preferred Stock.
(2) Pursuant to the Put, in exchange for the shares of Common Stock  reported on
Table I, the  Reporting  Person  received  the  shares of  Series A  Convertible
Preferred Stock reported on Table II.
(3) Upon the  earliest of (i) the approval by the holders of Common Stock of the
Issuer  of  the  transactions   contemplated  by  the  Purchase  Agreement  (the
"Transactions") that are required by Rule 4460(i) of the National Association of
Securities  Dealers'  Marketplace  Rules,  (ii) any  event  which  renders  such
stockholder  approval  unnecessary or which renders such Rule  inapplicable  and
(iii)  September 30, 1997,  in light of the Put, the  Reporting  Person shall no
longer be entitled  to a  distribution  of  additional  shares of Common  Stock,
however, the conversion price of the Series A Convertible  Preferred Stock shall
be adjusted to equal the lesser of $.29 and 50% of various market-based prices.

SIGNATURE OF REPORTING PERSON
/s/Lindsay A. Rosenwald, M.D.
- -----------------------------
Lindsay A. Rosenwald, M.D., President
Paramount Capital Asset Management, General Partner
Aries Domestic Fund, L.P.

DATE
09/09/97

<PAGE>

                                  Attachment A

        Reporting Person:           The Aries Domestic Fund, L.P.
        Issuer:                     Procept Incorporated (PRCT)
        Statement For:              August/1997

         Paramount Capital Asset  Management,  Inc.  ("Paramount"),  the General
Partner of the Aries Domestic Fund, L.P. (the "Partnership"), also serves as the
Investment  Manager to The Aries Trust (the  "Trust"),  a Cayman  Islands Trust,
which also owns  securities of the Issuer.  Lindsay A.  Rosenwald,  M.D., is the
sole shareholder of Paramount.  Paramount and Dr. Rosenwald disclaim  beneficial
ownership of the securities held by the Partnership and the Trust, except to the
extent of their pecuniary interest therein, if any.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission